Vascular resistance and endothelial function in cyclosporine-treated lung transplant recipients

Transplant International

Volumn 19, Issue 12, 2006, Pages 974-981

  Silverborn, Martin ^a   Ambring, Anneli ^a   Nilsson, Folke ^a   Friberg, Peter ^a   Jeppsson, Anders ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Endothelium; Hypertension; Immunosuppression; Lung transplantation; Vascular function

Indexed keywords

ACETYLCHOLINE; AZATHIOPRINE; CYCLOSPORIN A; ENDOTHELIN 1; GLYCERYL TRINITRATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; N(G) METHYLARGININE; NITRIC OXIDE; PREDNISONE; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD FLOWMETRY; BLOOD VESSEL REACTIVITY; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; ENDOTHELIUM CELL; FEMALE; FOREARM BLOOD FLOW; GRAFT RECIPIENT; HUMAN; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; VASCULAR RESISTANCE; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY;

ADULT; ANTIGENS; BLOOD PRESSURE; CYCLOSPORINE; ENDOTHELIAL CELLS; ENDOTHELIN-1; FEMALE; HEART RATE; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASCULAR RESISTANCE;

EID: 33750587525     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2006.00372.x     Document Type: Article

References (36)

1. Taylor DO, Trulock EP, et al. The registry of the international society for heart and lung transplantation: nineteenth official report-2002. J Heart Lung Transplant 2002; 21: 950.
2. Jenkins GH, Singer DR. Hypertension in thoracic transplant recipients. J Hum Hypertens 1998; 12: 813.
3. Morrison RJ, Short HD, Noon GP, Frost AE. Hypertension after lung transplantation. J Heart Lung Transplant 1993; 12: 928.
4. Ventura HO, Malik FS, Mehra MR, Stapleton DD, Smart FW. Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine. Curr Opin Cardiol 1997; 12: 375.
5. Silverborn M, Jeppsson A, Martensson G, Nilsson F. New-onset cardiovascular risk factors in lung transplant recipients. J Heart Lung Transplant 2005; 24: 1536.
6. Miller LW. Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2002; 2: 807.
7. Ventura HO, Milani RV, Lavie CJ, et al. Cyclosporine-induced hypertension. Efficacy of omega-3 fatty acids in patients after cardiac transplantation. Circulation 1993; 88: II281.
8. Textor SC, Taler SJ, Canzanello VJ, Schwartz L, Augustine JE. Posttransplantation hypertension related to calcineurin inhibitors. Liver Transpl 2000; 6: 521.
9. Silverborn M, Ambring A, Nilsson F, Friberg P, Jeppsson A. Blunted vascular response to endothelin-a receptor blockade in cyclosporine-treated lung transplant recipients. J Heart Lung Transplant 2005; 24: 665.
10. Silverborn M, Ambring A, Nilsson F, Friberg P, Jeppsson A. Increased arterial stiffness in cyclosporine-treated lung transplant recipients early after transplantation. Clin Transplant 2004; 18: 473.
11. Bracht C, Yan XW, LaRocca HP, Sutsch G, Kiowski W. Cyclosporine A and control of vascular tone in the human forearm: influence of post-transplant hypertension. J Hypertens 1999; 17: 357.
12. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 1995; 25: 918.
13. Carrier M, Tronc F, Stewart D, Pelletier LC. Dose-dependent effect of cyclosporin on renal arterial resistance in dogs. Am J Physiol 1991; 261: H1791.
14. Medina J, Cordier A, Wolf A. Cyclosporine A-induced contraction of isolated rat aortic smooth muscle cells. Life Sci 1997; 61: 327.
15. Grieff M, Loertscher R, Shohaib SA, Stewart DJ. Cyclosporine-induced elevation in circulating endothelin-1 in patients with solid-organ transplants. Transplantation 1993; 56: 880.
16. Abassi ZA, Pieruzzi F, Nakhoul F, Keiser HR. Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat. Hypertension 1996; 27: 1140.
17. Diederich D, Yang Z, Luscher TF. Chronic cyclosporine therapy impairs endothelium-dependent relaxation in the renal artery of the rat. J Am Soc Nephrol 1992; 2: 1291.
18. Bossaller C, Forstermann U, Hertel R, Olbricht C, Reschke V, Fleck E. Ciclosporin A inhibits endothelium-dependent vasodilatation and vascular prostacyclin production. Eur J Pharmacol 1989; 165: 165.
19. van den Dorpel MA, van den Meiracker AH, Lameris TW, Weimar W, Man in't Veld AJ. Forearm vasorelaxation in hypertensive renal transplant patients: the impact of withdrawal of cyclosporine. J Hypertens 1998; 16: 331.
20. Passauer J, Lassig G, Bussemaker E, Pistrosch F, Gross P. Reduced endothelin-1- and nitric oxide-mediated arteriolar tone in hypertensive renal transplant recipients. Kidney Int 2004; 65: 1782.
21. Holm T, Aukrust P, Andreassen AK, et al. Peripheral endothelial dysfunction in heart transplant recipients: possible role of proinflammatory cytokines. Clin Transplant 2000; 14: 218.
22. Cifkova R, Pit'ha J, Trunecka P, et al. Blood pressure, endothelial function and circulating endothelin concentrations in liver transplant recipients. J Hypertens 2001; 19: 1359.
23. Perez Fontan M, Rodriguez-Carmona A, Garcia Falcon T, Fernandez Rivera C, Valdes F. Early immunologic and nonimmunologic predictors of arterial hypertension after renal transplantation. Am J Kidney Dis 1999; 33: 21.
24. Albillos A, Cacho G, Barrios C, et al. Selective impairment of endothelium-mediated vasodilation in liver transplant recipients with cyclosporin A-induced hypertension. Hepatology 1998; 27: 332.
25. Hausberg M, Kisters K, Kosch M, Rahn KH, Barenbrock M. Flow-mediated vasodilation and distensibility of the brachial artery in renal allograft recipients. Kidney Int 1999; 55: 1104.
26. Stroes ES, Luscher TF, de Groot FG, Koomans HA, Rabelink TJ. Cyclosporin A increases nitric oxide activity in vivo. Hypertension 1997; 2: 570.
27. Bunchman TE, Brookshire CA. Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest 1991; 88: 310.
28. Letizia C, De Biase L, Caliumi C, et al. Endothelin-1 circulating levels increase in patients with orthotopic heart transplantation and in chronic therapy with cyclosporine. Minerva Cardioangiol 2001; 49: 15.
29. Cauduro RL, Costa C, Lhulier F, et al. Endothelin-1 plasma levels and hypertension in cyclosporine-treated renal transplant patients. Clin Transplant 2005; 19: 470.
30. Trapp A, Weis M. The impact of immunosuppression on endothelial function. J Cardiovasc Pharmacol 2005; 45: 81.
31. Bloom IT, Bentley FR, Garrison RN. Acute cyclosporine-induced renal vasoconstriction is mediated by endothelin-1. Surgery 1993; 114: 480.
32. Schiffrin EL. State-of-the-Art lecture. Role of endothelin-1 in hypertension. Hypertension 1999; 34: 876.
33. Galatius S, Wroblewski H, Sorensen VB, Bie P, Parving HH, Kastrup J. Endothelin and von Willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy: different stimuli for release before and after heart transplantation? Am Heart J 1999; 137: 549.
34. Blann AD, McCollum CN. von Willebrand factor, endothelial cell damage and atherosclerosis. Eur J Vasc Surg 1994; 8: 10.
35. Hunt BJ, Segal H, Yacoub M. Hemostatic changes in heart transplant recipients and their relationship to accelerated coronary sclerosis. Transplantation 1993; 55: 309.
36. Higashi Y, Yoshizumi M. New methods to evaluate endothelial function: method for assessing endothelial function in humans using a strain-gauge plethysmography: nitric oxide-dependent and -independent vasodilation. J Pharmacol Sci 2003; 93: 399.